News | April 05, 2022
BSV strengthens women's health portfolio by acquiring Tidilan brand
It is currently available in tablet and injectable dosage forms
It is currently available in tablet and injectable dosage forms
Trescal provides precision calibration expertise in every industry, geography and instrument across the world
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
Sanofi’s DE&I Board will include three of the most influential voices in the DE&I space as Board members appointed for 3 years: organizational psychologist & best-selling author John Amaechi, award-winning social entrepreneur Caroline Casey, and DE&I pioneer and renowned thought-leader Dr. Rohini Anand
Highly prestigious award endowed with €500,000 to uphold the United Nations 2030 Agenda
There is also a strong synergy between Jubilant and Greencure with respect to OTC portfolio which can be explored for R&D, online acceleration and offline distribution
The organization has introduced an advanced FlashMicelle technology which is a combination of ultra-rapid mixing techniques, and a uniquely powerful approach to modify the structure of oil-based formulations to improve their therapeutic efficacy substantially
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
The plant is scheduled to come on stream in September 2024
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
Subscribe To Our Newsletter & Stay Updated
